Approval · Notice of Compliance 2138 · 2001
MONONINE: Notice of Compliance 2138
Issued April 4, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2138
- Date
- April 4, 2001
- Company
- Aventis Behring LlcKing Of Prussia, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Blood coagulation product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MONONINE | 02228963 | — |
| MONONINE | 02228971 | — |
| MONONINE | 02228998 | — |
Medicinal ingredients
- COAGULATION FACTOR IX (HUMAN) 250 UNIT per VIAL
- COAGULATION FACTOR IX (HUMAN) 500 UNIT per VIAL
- COAGULATION FACTOR IX (HUMAN) 1,000 UNIT per VIAL